VERTEX PHARMACEUTICALS INC (VRTX) Stock Balance Sheet
NASDAQ:VRTX • US92532F1003
Current stock price
440.915 USD
+5.27 (+1.21%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.61B | 4.57B | 10.37B | 10.50B | 6.79B | |||
| Marketable Securities | 1.52B | 1.55B | 849.20M | 274.50M | 729.90M | |||
| Receivables | 2.05B | 1.61B | 1.56B | 1.44B | 1.14B | |||
| Inventories | 1.69B | 1.21B | 738.80M | 460.60M | 353.10M | |||
| Other Current Assets | 853.30M | 665.70M | 623.70M | 553.50M | 545.80M | |||
| Total Current Assets | 11.20B | 9.60B | 14.14B | 13.23B | 9.56B | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.08B | 2.58B | 1.45B | 1.46B | 1.42B | |||
| Investments And Advances | 5.79B | 5.17B | 2.60B | 98.60M | 85.80M | |||
| Goodwill | 1.09B | 1.09B | 1.09B | 1.09B | 1.00B | |||
| Intangibles | 490.80M | 888.50M | 898.80M | 603.60M | 400.00M | |||
| Other Non-Current Assets | 3.99B | 3.20B | 2.55B | 1.67B | 959.50M | |||
| Total Non-Current Assets | 14.44B | 12.94B | 8.59B | 4.92B | 3.87B | |||
| TOTAL ASSETS | 25.64B | 22.53B | 22.73B | 18.15B | 13.43B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.50M | 5.20M | 50.60M | 40.80M | 46.90M | |||
| Accrued Expenses | 2.95B | 2.71B | 2.59B | 2.05B | 1.50B | |||
| Accounts Payable | 3.89B | 413.00M | 364.90M | 303.90M | 195.00M | |||
| Other Current Liabilities | 448.60M | 431.80M | 543.00M | 345.40M | 399.50M | |||
| Total Current Liabilities | 3.86B | 3.56B | 3.55B | 2.74B | 2.14B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 106.70M | 112.80M | 376.10M | 430.80M | 509.80M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 3.01B | 2.45B | 1.23B | 1.07B | 680.70M | |||
| Total Non-Current Liabilities | 3.12B | 2.56B | 1.60B | 1.50B | 1.19B | |||
| TOTAL LIABILITIES | 6.98B | 6.12B | 5.15B | 4.24B | 3.33B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 13.56B | 9.61B | 10.14B | 6.52B | 3.20B | |||
| Additional Paid In Capital | 5.12B | 6.67B | 7.45B | 7.39B | 6.88B | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 2.50M | 2.60M | 2.60M | 2.60M | 2.50M | |||
| Other Shareholders' Equity | -49.90M | 120.70M | -23.90M | 900.00K | 16.40M | |||
| Shares Outstanding | 253.99M | 256.94M | 257.69M | 257.01M | 254.48M | |||
| Tangible Book Value per Share | 67.27 | 56.17 | 60.51 | 47.55 | 34.18 | |||
| Total Shareholders' Equity | 18.67B | 16.41B | 17.58B | 13.91B | 10.10B | |||
| TOTAL LIABILITIES AND EQUITY | 25.64B | 22.53B | 22.73B | 18.15B | 13.43B | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | 0.02 | 0.03 | 0.05 | |||
| Current Ratio | 2.90 | 2.69 | 3.99 | 4.83 | 4.46 | |||
| Return On Assets (ROA) | 15.42% | -2.38% | 15.92% | 18.30% | 17.44% | |||
| Return On Equity (ROE) | 21.18% | -3.26% | 20.59% | 23.88% | 23.19% | |||
| Return On Invested Capital (ROIC) | 16.99% | 18.31% | 17.95% | 22.74% | 19.47% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 27.12% | 27.02% | 43.24% | 75.68% | 58.37% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 30.66% | 31.93% | 57.61% | 119.25% | 93.00% | |||
All data in USD , ROIC based on taxRate of 0.21